Engagement Is Survival: My Take on ASCO 2017
Don Dizon, MD: In addition to important clinical trial outcomes that evaluated novel strategies across tumor types, there were impressive studies aiming to help our patients live with cancer as well.
Don Dizon, MD: In addition to important clinical trial outcomes that evaluated novel strategies across tumor types, there were impressive studies aiming to help our patients live with cancer as well.
A case report that looks into a breast cancer survivor experiencing sex-related headaches after treatment.
Dr. Dizon and patient advocate Katherine O’Brien discuss the difficulty of communicating cancer and give advice on common miscommunications.
Editorial Board Member Don Dizon, MD, answers some questions about issues in breast cancer treatment today.
ChemotherapyAdvisor.com Editorial Board Member Don S. Dizon discusses survivorship issues from the 2013 Breast Cancer Symposium.